Phase 4 Chronic Kidney Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have received or are planning to receive the medication pegcetacoplan to treat a kidney condition called C3G or primary IC-MPGN.
- People who have signed and dated a consent form agreeing to take part (for children or young people under the legal age, a parent or legal guardian must sign this form, and the child may also need to give their agreement depending on local rules).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are already taking part in a separate research study using an unapproved or experimental treatment for C3G or primary IC-MPGN at the time they start pegcetacoplan.
- People who first started taking pegcetacoplan as part of a different interventional (hands-on) research study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +46 86972000
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Achieving urine protein-to-creatinine ratio (UPCR) of <1 g/g
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.